Mechanism progress of bronchial asthma cured by PPARγagonists / 中国基层医药
Chinese Journal of Primary Medicine and Pharmacy
; (12): 3352-3354, 2016.
Article
в Zh
| WPRIM
| ID: wpr-504098
Ответственная библиотека:
WPRO
ABSTRACT
Peroxisome proliferators -activated receptors γ(PPARγ)agonist is a kind of drugs that is widely used in the treatment of type 2 diabetes,also shows effects on hypertensive disease,regulating blood lipid metabolism, anti -atherosclerosis and inhibiting inflammatory response.In recent years,good effects of PPARγagonist have been found on different animal models of asthma,and production of proinflammatory cytokines can significantly be reduced. Airway remodeling can be reduced,and airway hyper responsiveness can be inhibited by PPARγagonist that provide theoretical basis on new drugs for asthma.The mechanism of bronchial asthma cured by PPARγagonists are reviewed briefly.
Полный текст:
1
База данных:
WPRIM
Язык:
Zh
Журнал:
Chinese Journal of Primary Medicine and Pharmacy
Год:
2016
Тип:
Article